Crossmark

In-depth Characterization of Photo-Stressed Antibody–Drug Conjugates by Mass Spectrometry

Crossref DOI link: https://doi.org/10.1208/s12248-026-01247-6

Published Online: 2026-05-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pan, Xiao https://orcid.org/0000-0002-4444-8275
Zhao, Yimeng https://orcid.org/0009-0004-7199-6383
Luo, Shukun https://orcid.org/0000-0002-2766-3125
Bulos, Joshua https://orcid.org/0009-0001-1480-3694
Zhong, Jieqiang https://orcid.org/0000-0002-0906-695X
Yan, Yuetian https://orcid.org/0000-0001-9032-7880
Wu, Zhijie https://orcid.org/0000-0002-9981-8114
Su, Yue https://orcid.org/0009-0004-1523-6283
Zhang, Sisi https://orcid.org/0009-0008-5525-1583
Wang, Shunhai https://orcid.org/0000-0003-4055-2187
Xiao, Hui https://orcid.org/0000-0001-9489-054X
Wang, Wenhua https://orcid.org/0009-0002-6653-2002
Liu, Dingjiang https://orcid.org/0000-0002-8665-2426
Li, Ning https://orcid.org/0000-0001-6750-4308
Qiu, Haibo https://orcid.org/0000-0002-8449-4233
License Information

Text and Data Mining valid from 2026-05-11

Version of Record valid from 2026-05-11
More Information

Article History

Received: 13 January 2026

Accepted: 20 April 2026

First Online: 11 May 2026

Declarations

:

: The authors declare the following competing financial interests: X.P., Y.Z., S.L., J.B., J.Z., Y.Y., Z.W., Y.S., S.Z., S.W., H.X., W.W., D.L., H.Q., and N.L. are full-time employees and shareholders of Regeneron Pharmaceuticals Inc.